Transgene Hopes To Finally Catch The Wave In Virus Based Immunotherapies

 
• By Sten Stovall

Transgene's CEO discusses its immunotherapy pipeline, coming catalysts, and why the French biotech may soon be swept up by growing interest in oncolytic viruses.

Wave
Building Momentum: Transgene Has nine Clinical Trial Read-Outs This Year • Source: Shutterstock

More from Clinical Trials

More from R&D